Header Logo

Payal Gurnani

Concepts (46)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pharmacists
2
2021
16
0.870
 Why?
Marfan Syndrome
1
2018
3
0.590
 Why?
Drug-Eluting Stents
1
2018
10
0.580
 Why?
Extracorporeal Membrane Oxygenation
1
2018
17
0.570
 Why?
Fluid Therapy
1
2010
24
0.330
 Why?
Shock, Septic
1
2010
59
0.330
 Why?
Practice Guidelines as Topic
1
2010
244
0.300
 Why?
Anti-Bacterial Agents
1
2010
362
0.270
 Why?
Professional Role
2
2021
28
0.210
 Why?
Epoprostenol
1
2021
6
0.180
 Why?
Pulmonary Ventilation
1
2021
6
0.180
 Why?
Nebulizers and Vaporizers
1
2021
12
0.180
 Why?
Antihypertensive Agents
1
2021
41
0.180
 Why?
Hypercalcemia
1
2020
5
0.170
 Why?
Calcitonin
1
2020
14
0.170
 Why?
Diphosphonates
1
2020
15
0.170
 Why?
Intubation, Intratracheal
1
2021
87
0.170
 Why?
Critical Care
1
2021
112
0.160
 Why?
Patient Care Team
1
2021
105
0.160
 Why?
Pandemics
1
2021
190
0.160
 Why?
Neoplasms
1
2020
213
0.140
 Why?
Intensive Care Units
1
2019
246
0.130
 Why?
Humans
6
2021
24703
0.130
 Why?
Emergency Service, Hospital
1
2019
245
0.120
 Why?
Adult
3
2021
7255
0.120
 Why?
Male
4
2021
13669
0.110
 Why?
Resuscitation
1
2010
11
0.080
 Why?
Clinical Protocols
1
2010
57
0.080
 Why?
Hospital Mortality
1
2010
121
0.080
 Why?
Evidence-Based Medicine
1
2010
158
0.080
 Why?
Multivariate Analysis
1
2010
304
0.080
 Why?
Middle Aged
3
2021
8294
0.070
 Why?
Aged
3
2021
8382
0.070
 Why?
Cross Infection
1
2010
291
0.070
 Why?
Time Factors
1
2010
1327
0.060
 Why?
Prospective Studies
1
2010
1612
0.060
 Why?
Female
3
2021
14048
0.060
 Why?
Retrospective Studies
2
2021
3156
0.050
 Why?
Treatment Outcome
1
2010
3208
0.050
 Why?
Reagent Kits, Diagnostic
1
2021
6
0.050
 Why?
Administration, Inhalation
1
2021
23
0.050
 Why?
Dose-Response Relationship, Drug
1
2021
314
0.040
 Why?
Case-Control Studies
1
2021
555
0.040
 Why?
Pharmacy Service, Hospital
1
2019
11
0.040
 Why?
Cost Savings
1
2019
30
0.040
 Why?
Critical Illness
1
2019
106
0.040
 Why?
Gurnani's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (46)
Explore
_
Co-Authors (6)
Explore
_
Similar People (58)
Explore
_
Same Department Expand Description
Explore
_